InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
10
T+90 hit rate
100%
T+90 mean return
+39.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Looker Benjamin, Conseiller Juridique. Insider active across 1 company, notably Esperion Therapeutics, Inc.. In total, 16 filings have been published. Split: 0 buy · 10 sells. Total volume traded: €106k. Activity tracked since 27 January 2022. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
667,524 sharesCommon StockSEC:0001628280-26-048001:0
11,824 sharesCommon StockSEC:0001628280-26-044269:0
5,708 shares@ US$2.70321.0% of flowCommon StockSEC:0001628280-26-019413:0
300,840 shares0Common StockSEC:0001628280-26-018194:0
1,689 shares@ US$2.8823.9% of flowCommon StockSEC:0001628280-26-002925:0
6,517 shares@ US$3.66720.0% of flowCommon StockSEC:0001628280-25-057941:0
1,248 shares@ US$2.62453.4% of flowCommon StockSEC:0001628280-25-045520:0
6,267 shares@ US$2.80418.9% of flowCommon StockSEC:0001859509-25-000004:0
1,304 shares@ US$1.1272.5% of flowCommon StockSEC:0001628280-25-035336:0
6,422 shares@ US$1.15213.1% of flowCommon StockSEC:0001628280-25-032219:0
224,000 shares0Common StockSEC:0001628280-25-013195:0
100,000 shares0Common StockSEC:0001628280-24-011490:0
1,290 shares@ US$1.2723.5% of flowCommon StockSEC:0001628280-23-012264:0
20,500 shares0Common StockSEC:0001628280-23-007971:0
6,347 shares@ US$6.99696.5% of flowCommon StockSEC:0001628280-23-001278:0
70,800 shares0Common StockSEC:0001628280-22-001471:0
16 of 16 declarations
About Looker Benjamin
Benjamin Looker is the General Counsel at Esperion Therapeutics, Inc. In this role, he is responsible for the company's legal and compliance matters, ensuring the protection of the organization's legal interests.
